(MEOH) Methanex - Ratings and Ratios
Methanol, Storage, Terminal
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.84% |
| Yield on Cost 5y | 1.76% |
| Yield CAGR 5y | 31.56% |
| Payout Consistency | 93.8% |
| Payout Ratio | 20.8% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 39.1% |
| Value at Risk 5%th | 57.7% |
| Relative Tail Risk | -10.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.28 |
| Alpha | -38.19 |
| CAGR/Max DD | 0.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.429 |
| Beta | 1.416 |
| Beta Downside | 1.752 |
| Drawdowns 3y | |
|---|---|
| Max DD | 52.16% |
| Mean DD | 21.08% |
| Median DD | 20.48% |
Description: MEOH Methanex November 10, 2025
Methanex Corporation (NASDAQ:MEOH) is the world’s largest dedicated producer of methanol, operating production facilities and a network of storage and terminal assets across Asia-Pacific, North America, Europe, and South America. The company primarily supplies methanol to downstream chemical and petrochemical manufacturers, and it has been publicly listed since its incorporation in 1968, with headquarters in Vancouver, Canada.
Key operational metrics (as of FY 2024) include roughly 5 million metric tons of methanol produced annually and an EBITDA margin that typically ranges between 15-20 % depending on natural-gas input costs. The firm’s earnings are highly sensitive to natural-gas price movements, which account for about 70-80 % of methanol production costs; a 10 % swing in gas prices can shift EBITDA by roughly ±2 percentage points. Additionally, demand drivers such as the growth of formaldehyde, acetic acid, and MTBE markets, especially in emerging economies, have been a primary long-term catalyst for volume growth.
For a deeper quantitative assessment, the ValueRay platform provides a granular breakdown of Methanex’s cash-flow sensitivity to natural-gas price swings and regional demand trends.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (213.8m TTM) > 0 and > 6% of Revenue (6% = 213.5m TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 4.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 22.05% (prev 11.43%; Δ 10.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 878.8m > Net Income 213.8m (YES >=105%, WARN >=100%) |
| Net Debt (3.20b) to EBITDA (945.6m) ratio: 3.38 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.09 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (77.3m) change vs 12m ago 14.57% (target <= -2.0% for YES) |
| Gross Margin 22.87% (prev 17.48%; Δ 5.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 50.83% (prev 56.97%; Δ -6.14pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.54 (EBITDA TTM 945.6m / Interest Expense TTM 211.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.54
| (A) 0.10 = (Total Current Assets 1.51b - Total Current Liabilities 721.8m) / Total Assets 7.52b |
| (B) 0.23 = Retained Earnings (Balance) 1.76b / Total Assets 7.52b |
| (C) 0.08 = EBIT TTM 537.1m / Avg Total Assets 7.00b |
| (D) 0.55 = Book Value of Equity 2.57b / Total Liabilities 4.65b |
| Total Rating: 2.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 52.77
| 1. Piotroski 5.50pt |
| 2. FCF Yield 12.03% |
| 3. FCF Margin 21.32% |
| 4. Debt/Equity 1.41 |
| 5. Debt/Ebitda 3.38 |
| 6. ROIC - WACC (= -0.07)% |
| 7. RoE 8.97% |
| 8. Rev. Trend -79.95% |
| 9. EPS Trend -42.07% |
What is the price of MEOH shares?
Over the past week, the price has changed by -1.05%, over one month by +10.00%, over three months by +0.38% and over the past year by -18.90%.
Is MEOH a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MEOH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.2 | 21.4% |
| Analysts Target Price | 48.2 | 21.4% |
| ValueRay Target Price | 41.2 | 3.8% |
MEOH Fundamental Data Overview December 28, 2025
P/E Trailing = 13.4866
P/E Forward = 12.6263
P/S = 0.8708
P/B = 1.2079
P/EG = 0.98
Beta = 1.107
Revenue TTM = 3.56b USD
EBIT TTM = 537.1m USD
EBITDA TTM = 945.6m USD
Long Term Debt = 2.79b USD (from longTermDebt, last quarter)
Short Term Debt = 158.6m USD (from shortTermDebt, last quarter)
Debt = 3.61b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.20b USD (from netDebt column, last quarter)
Enterprise Value = 6.31b USD (3.11b + Debt 3.61b - CCE 413.0m)
Interest Coverage Ratio = 2.54 (Ebit TTM 537.1m / Interest Expense TTM 211.6m)
FCF Yield = 12.03% (FCF TTM 758.8m / Enterprise Value 6.31b)
FCF Margin = 21.32% (FCF TTM 758.8m / Revenue TTM 3.56b)
Net Margin = 6.01% (Net Income TTM 213.8m / Revenue TTM 3.56b)
Gross Margin = 22.87% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.75b) / Revenue TTM)
Gross Margin QoQ = 7.38% (prev 27.07%)
Tobins Q-Ratio = 0.84 (Enterprise Value 6.31b / Total Assets 7.52b)
Interest Expense / Debt = 1.67% (Interest Expense 60.2m / Debt 3.61b)
Taxrate = 47.51% (3.75m / 7.90m)
NOPAT = 281.9m (EBIT 537.1m * (1 - 47.51%))
Current Ratio = 2.09 (Total Current Assets 1.51b / Total Current Liabilities 721.8m)
Debt / Equity = 1.41 (Debt 3.61b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 3.38 (Net Debt 3.20b / EBITDA 945.6m)
Debt / FCF = 4.21 (Net Debt 3.20b / FCF TTM 758.8m)
Total Stockholder Equity = 2.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.84% (Net Income 213.8m / Total Assets 7.52b)
RoE = 8.97% (Net Income TTM 213.8m / Total Stockholder Equity 2.38b)
RoCE = 10.38% (EBIT 537.1m / Capital Employed (Equity 2.38b + L.T.Debt 2.79b))
RoIC = 5.60% (NOPAT 281.9m / Invested Capital 5.04b)
WACC = 5.66% (E(3.11b)/V(6.72b) * Re(11.23%) + D(3.61b)/V(6.72b) * Rd(1.67%) * (1-Tc(0.48)))
Discount Rate = 11.23% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 6.98%
[DCF Debug] Terminal Value 65.08% ; FCFE base≈602.1m ; Y1≈535.1m ; Y5≈448.5m
Fair Price DCF = 65.51 (DCF Value 5.07b / Shares Outstanding 77.3m; 5y FCF grow -13.70% → 3.0% )
EPS Correlation: -42.07 | EPS CAGR: -59.86% | SUE: -2.11 | # QB: 0
Revenue Correlation: -79.95 | Revenue CAGR: -7.98% | SUE: -0.70 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.83 | Chg30d=-0.002 | Revisions Net=-2 | Analysts=5
EPS next Year (2026-12-31): EPS=3.31 | Chg30d=-0.112 | Revisions Net=-1 | Growth EPS=+8.2% | Growth Revenue=+11.5%
Additional Sources for MEOH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle